BlackRock
BTX.WS

BlackRock’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

BlackRock’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-50
Closed – – 5132
2018
Q2 		$0 Hold
50
– – ﹤0.01% 5142
2018
Q1 		$0 Hold
50
– – ﹤0.01% 5068
2017
Q4 		$0 Hold
50
– – ﹤0.01% 5046
2017
Q3 		$0 Hold
50
– – ﹤0.01% 5095
2017
Q2 		$0 Hold
50
– – ﹤0.01% 5144
2017
Q1 		$0 Hold
50
– – ﹤0.01% 5110
2016
Q4 		$0 Buy
+50
New +$34 ﹤0.01% 3846

BlackRock's BTX.WS Position: Q3 2018 in Review

BlackRock sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 50 shares.

BlackRock first reported a position in BTX.WS in Q4 2016 and held it in 7 quarters. The position peaked at $0 in Q2 2018. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • BlackRock reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • BlackRock sold 50 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018.
  • BlackRock first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2016 and held it in 7 quarters.
  • BlackRock's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q2 2018.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on BlackRock's 13F filing for Q3 2018, filed 9 Nov 2018.